Amphenol, Inc. (APH) Tops Q4 EPS by 3c, Posts Q1 and FY12 Guidance Ahead of Consensus
Get Alerts APH Hot Sheet
Price: $115.35 +0.04%
Revenue Growth %: +4.0%
Financial Fact:
Selling, general and administrative expense: 204.7M
Today's EPS Names:
FSI, RELV, NEOM, More
Revenue Growth %: +4.0%
Financial Fact:
Selling, general and administrative expense: 204.7M
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Amphenol, Inc. (NYSE: APH) reported Q4 EPS of $0.73, $0.03 better than the analyst estimate of $0.70. Revenue for the quarter came in at $949 million versus the consensus estimate of $932.27 million.
Amphenol, Inc. sees Q1 2012 EPS of $0.73-$0.76, versus the consensus of $0.71. Amphenol, Inc. sees Q1 2012 revenue of $960-$975 million, versus the consensus of $938.1 million.
Amphenol, Inc. sees FY2012 EPS of $3.23-$3.34, versus the consensus of $3.18. Amphenol, Inc. sees FY2012 revenue of $4.05-$4.15 billion, versus the consensus of $4.04 billion.
For earnings history and earnings-related data on "Amphenol, Inc. (APH)" click here.
Amphenol, Inc. sees Q1 2012 EPS of $0.73-$0.76, versus the consensus of $0.71. Amphenol, Inc. sees Q1 2012 revenue of $960-$975 million, versus the consensus of $938.1 million.
Amphenol, Inc. sees FY2012 EPS of $3.23-$3.34, versus the consensus of $3.18. Amphenol, Inc. sees FY2012 revenue of $4.05-$4.15 billion, versus the consensus of $4.04 billion.
For earnings history and earnings-related data on "Amphenol, Inc. (APH)" click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- Midday movers: RH, Estee Lauder rise; Tesla falls
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!